Delivery Order SPE2DR25D2002-SPE2DR26FBST1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,613.04 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pen injections on August 26, 2025. This firm fixed-price contract, which is a child delivery order under a larger indefinite delivery contract vehicle, represents a competitively awarded procurement with no set-aside designation. The order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,534.20 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on November 17, 2025, with an ultimate completion date of November 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,406.34 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen injections on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order, which is a child contract under a larger vehicle, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $1,744.44 under a firm fixed-price contract type. This non-set-aside award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution hub for federal medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,744.44 for Trulicity 4.5 mg/0.5 mL pen injectors, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement action fulfilling federal medical supply requirements for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,095.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by December 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $4,564.98. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBST1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injections valued at $1,582.40, with an ultimate completion date of December 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Trulicity, a diabetes medication, represents one of the many therapeutic drug categories delivered under this prime contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/17/25 |